Feature image (L–R) | Hudson Institute Ovarian Cancer researcher, Dr Maree Bilandzic
and Ovarian Cancer Research Foundation (OCRF) Ambassador and patient, Leane Flynn

Ovarian cancer

Ovarian cancer is the tenth most common cancer in Australia, and a silent killer. It is often asymptomatic and goes undetected until the advanced stages, when the cancer is widespread.

Only a handful of new treatment options have emerged in the past 30 years, and these typically become ineffective as the cancer develops resistance to chemotherapy.

What is ovarian cancer?

Ovarian cancer signs and symptoms

Causes and risks of ovarian cancer

Stages of ovarian cancer

Ovarian cancer treatment

Our ovarian cancer research

Hudson Institute scientists are advancing understanding of epithelial tumours and the more rare granulosa cell tumours. Our researchers are working towards the development of an early detection test and new treatments for ovarian cancer.

Detecting and treating ovarian cancer

Led by Dr Andrew Stephens, the Ovarian Cancer Biomarkers research group is focused on creating a future free of ovarian cancer by developing an early detection test and better treatments to achieve long-lasting cancer remission.

“The fact is that no early detection test for ovarian cancer exists – it’s a simple necessity we owe women.” – Dr Maree Bilandzic, Senior Postdoctoral Researcher

Our teams projects

  • Development and preclinical testing of a new cancer drug
  • Understanding and targeting invasive tumours
  • Creation of early detection tests
  • Combination therapies to improve patient response to current treatments
  • Precision medicine approaches to rapidly personalise therapy

Hope for children and women with GCT

Closing in on ovarian cancer treatments

Ovarian cancer collaborators

Support for people with Ovarian cancer

Our scientists cannot provide medical advice.
To find out about ovarian cancer, please visit (see list of useful organisations below).

Share this page